RxDoctor Payments Data

Kassandre Balocca, PA

Physician Assistant · Tulsa, OKNPI 1205258027

Payments from drug & device makers

$1,289in general payments, 2019–2025

Across 75 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$369
  • Merck$235
  • Pfizer$187
  • Amgen$88
  • E.r. Squibb & Sons, L.L.C.$82
  • Johnson & Johnson$54
  • plus $274 from 10 others

What the payments were for

  • Food & beverage$1,27699%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,289 in reported general payments places this provider in the 70th percentile of 1,491 physician assistant providers in Oklahoma.

See all physician assistant providers in Oklahoma

Medicare billing

Part B allowed, 2024
$97,415
Medicare patients
730
Services billed
999

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban216$218,790
XareltoRivaroxaban105$75,949
EntrestoSacubitril/Valsartan50$50,577
JardianceEmpagliflozin42$39,124
Repatha SureclickEvolocumab51$33,937
BrilintaTicagrelor42$27,696
VascepaIcosapent Ethyl21$10,369
VerquvoVericiguat11$7,152
LivaloPitavastatin Calcium15$6,362
Atorvastatin Calcium386$5,495
Metoprolol Succinate416$4,904
Ezetimibe139$4,508
Ranolazine ErRanolazine69$4,159
Rosuvastatin Calcium140$2,481
Amlodipine Besylate293$2,344

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$187$218,790216 claims
Johnson & JohnsonXarelto$54$75,949105 claims
NovartisEntresto$369$50,57750 claims
AstraZenecaBrilinta$14$27,69642 claims
MerckVerquvo$235$7,15211 claims
Kowa Pharmaceuticals America, Inc.Livalo$24$6,36215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,491 physician assistant providers in Oklahoma.

Other physician assistant in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →